Ocimum Biosolutions, a leading provider of Innovative Bioinformatics solutions and Laboratory nformation Management System (LIMS) ,announced that it has licensed Genowiz™ to Bioniche Therapeutics Research Center of Bioniche Life Sciences Inc and to the University of Ottawa, Canada. Ocimum’s CEO Anuradha Acharya remarked, “Bioniche is a forward thinking premiere biopharmaceutical company committed to sustain and advance the clinical development of its drug discovery program. University of Ottawa houses one of the most active biological research labs. We expect that Genowiz™ will meet their requirements and also greatly heighten their research work in the field of microarrays. We are proud to have such prestigious organizations in our client list”. Financial details of the deal were not disclosed.
